What Is Neo? Chemoimmunotherapy in the Neoadjuvant Setting for Resectable Non-Small-Cell Lung Cancer

被引：10
|
作者：
Shu, Catherine A. [1 ]
Cascone, Tina [2 ]
机构：
[1] Columbia Univ, Dept Med, Div Hematol Oncol, 161 Ft Washington Ave,3rd Floor, New York, NY 10025 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 26期
关键词：
PATHOLOGICAL RESPONSE; SINGLE-ARM; OPEN-LABEL; CHEMOTHERAPY; MULTICENTER; SURVIVAL; BLOCKADE; TUMOR;
D O I：
10.1200/JCO.21.01446
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：2855 / +
页数：5
相关论文
共 50 条
  • [31] Neoadjuvant chemotherapy for resectable non-small cell lung cancer
    Finkelstein, EI
    Urschel, JD
    Takita, H
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1997, 16 (04) : 437 - 439
  • [32] Neoadjuvant immunotherapy for resectable non-small cell lung cancer
    Xie, Hui
    Shi, Xuejun
    Wang, Guangshun
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (06): : 2521 - 2536
  • [33] Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer
    Lochrin, Sarah E.
    Forde, Patrick M.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (08) : 415 - 423
  • [34] Neoadjuvant therapy for resectable non-small cell lung cancer
    Welcker, Katrin
    Jonigk, Danny
    Kropf-Sanchen, Cornelia
    Tufman, Amanda
    Draube, Andreas
    Stenzinger, Albrecht
    Zaatar, Mohamed
    Thomas, Michael
    PNEUMOLOGIE, 2025, 79 (01): : 16 - 24
  • [35] Comparison of neoadjuvant chemoimmunotherapy with planned surgery and concurrent chemoradiation followed by immunotherapy for potentially resectable stage III non-small-cell lung cancer: a retrospective study
    Qi, Yana
    Zhai, Xiaoyang
    Xu, Qinhao
    Jin, Yuqin
    Guo, Yingfan
    Zhao, Miaoqing
    Zhu, Hui
    Guo, Hongbo
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2025, 74 (04)
  • [36] Revisiting neoadjuvant therapy in non-small-cell lung cancer
    Saw, Stephanie P. L.
    Ong, Boon-Hean
    Chua, Kevin L. M.
    Takano, Angela
    Tan, Daniel S. W.
    LANCET ONCOLOGY, 2021, 22 (11): : E501 - E516
  • [37] Outcomes of Resectable Locally Advanced Non-Small Cell Lung Cancer After Neoadjuvant Chemoimmunotherapy: A Single Institution Experience
    Noy, Jose
    Chang, Alexander
    Chow, Nelly P.
    De Jesus Fernandez, Javier
    Dureja, Rohan
    Cotamo, Luis Miguel
    Alnajar, Ahmed
    Nguyen, Dao M.
    Villamizar, Nestor
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (03)
  • [38] Maturation and abundance of tertiary lymphoid structures are associated with the efficacy of neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer
    Sun, Xiaoyan
    Liu, Weiran
    Sun, Leina
    Mo, Huilan
    Feng, Yingnan
    Wu, Xinyi
    Li, Chenguang
    Chen, Chen
    Li, Jingjing
    Xin, Ying
    Zhang, Zhenfa
    Wang, Changli
    Zhang, Bin
    Yue, Dongsheng
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (11)
  • [39] A real-world comparison between neoadjuvant chemoimmunotherapy and chemotherapy alone for resectable non-small cell lung cancer
    Zhang, Baihua
    Xiao, Haifan
    Pu, Xingxiang
    Zhou, Chunhua
    Yang, Desong
    Li, Xu
    Wang, Wenxiang
    Xiao, Qin
    CANCER MEDICINE, 2023, 12 (01): : 274 - 286
  • [40] Chemotherapy and radiotherapy in the treatment of resectable non-small-cell lung cancer
    Bernstein, ED
    Herbert, SM
    Hanna, NH
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (03) : 291 - 301
12345